Delivering CRISPR therapeutics with lipid nanoparticles
US10626393B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2016 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Jun 9, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides lipid particles comprising therapeutic nucleic acids such as gRNA that target gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.